Source: International Congress 2016 – Pulmonary drug delivery
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Per Wollmer (Malmø, Sweden), Laura Aaltonen, Hanna Nicklasson, Jonas Jakobsson, Sophia Zackrisson, Jakob Löndahl, Per Wollmer. Deposition of inhaled nanoparticles, airflow obstruction and emphysema. Eur Respir J 2016; 48: Suppl. 60, 974

Member's Comments

No comment yet.

Related content which might interest you: Calculation of peripheral airspace dimensions from deposition of inhaled nanoparticles Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016 Small airway function in smokers without airway obstruction Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Small airway abnormalities in elderly asthmatics with fixed airflow obstruction vs. COPD: High-resolution CT and pulmonary functions Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Eosinophilic versus non-eosinophilic COPD cannot be distinguished by lung function nor CT determined emphysema or airway remodelling Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Double-tracer gas washout in stable asthma and COPD Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Lobar variation of emphysema impacts lung function Source: International Congress 2015 – A more functional view of chest pathology Year: 2015 Bronchodilator treatment response mapping in COPD using hyperpolarised gas ventilation MRI Source: Annual Congress 2013 –The different modalities for current imaging and for future issues Year: 2013 Is airflow obstruction associated with nontuberculous lesions on chest X-ray? Source: International Congress 2016 – Multidimensional and multidisciplinary approaches to respiratory problems Year: 2016 Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Airway wall volume: Implications for the CT characterization of airway disease in smokers Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked Year: 2013 Hemodynamic effects of inhaled fenoterol and ipratropium in patients with obstructive pulmonary diseases Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Pulmonary response to salbutamol inhalation using dynamic OE-MRI in patients with asthma Source: Annual Congress 2013 –The different modalities for current imaging and for future issues Year: 2013 Small airway dysfunction is associated to the excessive bronchoconstriction in asthma Source: International Congress 2014 – Lung function testing: new findings and new approaches Year: 2014 Association between airflow obstruction and arterial stiffness Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013 Do all COPD patients present irreversible airflow limitation? Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles Year: 2013 Drug particle size and lung deposition in COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Lung functions and imaging characteristics of the patients with combined pulmonary fibrosis and emphysema Source: International Congress 2015 – IPF: clinical aspects Year: 2015 The relationship of small airways disease to spirometry and emphysema in alpha-1 antitrypsin deficiency Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 First dose response to tiotropium in COPD: Impact on dyspnea, lung hyperinflation and distal airways Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013